MedPath

INTRA-AMNIOTIC SURFACTANT USE FOR PREVENTING RESPIRATORY DISTRESS SYNDROME IN PRETERM BIRTH

Not Applicable
Conditions
Health Condition 1: null- Pregnant women between 28-34 weeks of gestational age, before preterm birth
Registration Number
CTRI/2015/12/006399
Lead Sponsor
Project under thesis at All India Institute of Medical Sciences New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Pregnant women at 28-34 weeks of gestational age, in preterm labour or before preterm caesarean section

Exclusion Criteria

Preterm premature rupture of membranes, chorioamnionitis, congenital fetal malformations, positive foam stability test (for lung maturity) in amniotic fluid

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of respiratory distress syndrome (RDS),severity of RDS, need of postnatal intra-tracheal surfactantTimepoint: Outcome was assessed at the time of delivery and till discharge of baby from nursery
Secondary Outcome Measures
NameTimeMethod
APGAR score (at 1 and 5 minutes after birth), foam stability test of gastric lavage, FiO2 requirement of CPAP and its duration, need of mechanical ventilation and its duration, length of hospital stayTimepoint: once
© Copyright 2025. All Rights Reserved by MedPath